Disagreements regarding the treatment/enhancement distinction involve the plausibility of the distinction itself, whether it is morally or practically significant, where and how to draw the line between treatment and enhancement, and the implications of categorizing interventions on either side of the line (Anderson, 1989 ; Bess, 2010 ; Juengst & Moseley, 2019 ; Juengst, 1997 ; Parens, 1998 ).
← all excerpts
The Ethics of Human Embryo Editing via CRISPR-Cas9 Technology: A Systematic Review of Ethical Arguments, Reasons, and Concerns.
1
—
—